Board certified psychiatrist and psychoanalyst, Gita Vaid, M.D., has been not just researching psychedelic-assisted therapy in her practice, but she has found it to be a successful tool for treating depression in some of her patients. Her area of expertise is specifically with ketamine and she tells all to mbg founder and co-CEO, Jason Wachob.

Learn how psychedelics have the potential to shift how we view and manage our mental health, plus the power of emotional connection and why we should make time to sit with our thoughts. Tune in to this episode to find out what happens during a typical doctor-monitored ketamine-assisted therapy session and how it can help people better access their emotions.

To contact the mindbodygreen team with comments, questions, or speaker ideas, please email podcast@mindbodygreen.com. For all sponsorship inquiries, please email sales@mindbodygreen.com. Want to join our podcast email newsletter? Sign up here!

Enjoy this episode! And don't forget to subscribe to our podcast on iTunes, Google Play, or Stitcher, and sign up for our podcast newsletter!

Learn more about your ad choices. Visit megaphone.fm/adchoices

177: Ketamine, MAPS & what’s next for psychedelic-assisted therapy with Gita Vaid, M.D.